文献
J-GLOBAL ID:201902290795325742
整理番号:19A1970136
再発または難治性骨髄腫患者におけるダラツマブ,ポマmalおよびデキサメタゾンの臨床効果:難治性患者におけるダルツマブによる再治療の有用性【JST・京大機械翻訳】
Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patients
著者 (8件):
Nooka Ajay K.
(Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia)
,
Joseph Nisha S.
(Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia)
,
Kaufman Jonathan L.
(Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia)
,
Heffner Leonard T.
(Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia)
,
Gupta Vikas A.
(Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia)
,
Gleason Charise
(Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia)
,
Boise Lawrence H.
(Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia)
,
Lonial Sagar
(Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia)
資料名:
Cancer (Hoboken, N.J.)
(Cancer (Hoboken, N.J.))
巻:
125
号:
17
ページ:
2991-3000
発行年:
2019年
JST資料番号:
D0781B
ISSN:
0008-543X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)